TL;DR
Get beauty and skincare favorites delivered free with Prime
- Fast, free delivery on millions of items
- Prime Video, Amazon Music and more included
- Member-only deals all year
Global Cosmetics News’ Week 43 review reports mixed sales results, regulatory developments and corporate changes across beauty and personal care. It also highlights retail disruption in France and Italy and a Russian attack that halted production at Ukrainian manufacturer 2K.
Global Cosmetics News’ Week 43 review describes a mixed week for the global cosmetics and personal care industry, pairing growth at companies including P&G and Puig with weaker online beauty sales in China, new compliance measures and disruption to retail and manufacturing. The roundup spans financial results, portfolio and leadership changes, and developments affecting product safety and market access.
On financial performance, the review says P&G reported 4 percent sales growth in fiscal first-quarter 2027, supported by its Beauty division. Puig recorded what the roundup describes as record third-quarter sales, with make-up and Asia-Pacific contributing to growth. Dolce & Gabbana Beauty set a target of double-digit growth through international expansion. By contrast, online beauty sales in China fell 6 percent in September, amid weaker demand and increased competition for multinational brands, according to the report.
Other business developments included THG raising its 2026 profit forecast, with growth attributed to its nutrition business, and Walmart targeting a US$6.5 billion bond sale to support retail expansion. Malaysia’s Big Caring Pharmacy chain outlined a US$600 million IPO plan. Getty Images filed for bankruptcy protection as it faced AI competition and debt restructuring, the roundup says.
Portfolio and leadership changes included Unilever’s sale of Welly to Forward Consumer Partners and Solabia’s shift in focus toward cosmetics and nutraceuticals following Muriel Koch’s appointment as CEO. Proya Cosmetics opened a European innovation laboratory in France. The week also brought board and executive moves at dsm-firmenich, Chanel, Dermalogica and L’Oréal, alongside brand partnerships and ambassador appointments.
Growth Meets Market Pressure
The roundup’s central business signal is uneven performance across markets and companies. Growth at P&G and Puig sits alongside the reported decline in China’s online beauty sales, indicating that results vary by region and channel rather than moving uniformly across the sector. Expansion ambitions, including Dolce & Gabbana Beauty’s international plans, are unfolding against that varied backdrop.
Regulatory changes could affect how products and services are sold. The UK proposed tighter restrictions on some high-risk cosmetic procedures, while Indonesia extended halal certification deadlines for cosmetics and personal care products to 2028. For companies operating across borders, the developments put compliance and product safety alongside commercial growth as immediate business concerns. Separately, the reported damage to shops and the shutdown of a Ukrainian manufacturer show how unrest and conflict can disrupt sales and supply.
Products Worth Considering
Hyperice Normatec Elite Wireless Compression Boots Recovery – Standard Size
Therabody Theragun Relief Massage Gun, 3-Speed, Black
Bowflex PR1000 Home Gym
As an affiliate, we earn on qualifying purchases.
A Week Across Beauty Markets
The review brings together developments across financial performance, regulation, corporate strategy and operations; it is a weekly roundup, not a single company announcement or a unified industry forecast. Its reported sales figures refer to different periods and measures: P&G’s fiscal first quarter, Puig’s third quarter and Chinese online sales in September. Those figures should not be treated as directly comparable.
The regulatory items also differ in status. The UK measures are described as proposed restrictions, while Indonesia’s certification deadline extension is reported as a change to the compliance timetable. In the United States, the FDA cleared a Phase 2 clinical trial investigating injectable PDGF for under-eye hollows. That clearance concerns a clinical study, not a conclusion that the treatment is effective or approved for general use. Kenvue also updated labelling and safety documentation for Neutrogena Oil-Free Acne Stress Control Triple Action Toner, identifying it as an over-the-counter acne treatment.
International investment featured in Proya’s opening of a French innovation laboratory, while the roundup also describes retail closures amid civil unrest in France and Milan. These events put market expansion and local operating risks side by side.
Details Still to Be Confirmed
The source is a summary and does not provide underlying filings, full company statements or detailed figures for every item. It does not specify the sales values behind Puig’s reported record quarter, the precise basis for several growth claims, or the extent of the companies’ outlooks beyond the short descriptions.
The UK cosmetic-procedure restrictions are described as proposed, so their final form and implementation timetable are not established in the roundup. The report also gives no detailed timetable or results for the Phase 2 PDGF study. The scale and duration of retail closures and the production halt at 2K, as well as the steps required before operations resume, remain unclear from the source.
Regulatory and Business Follow-Up
Companies and readers will be watching for further details on the UK proposals and how businesses will use Indonesia’s extended certification period before the 2028 deadline. Future company reporting can clarify whether the sales trends in China and the growth reported by P&G and Puig continue into later reporting periods.
The FDA-cleared study will need to proceed through its clinical phase before its findings can be assessed; the roundup does not state when results are expected. Further updates are also needed on the proposed IPO, the bond sale target and the operational impact of the reported unrest and attack on manufacturing. The weekly review does not provide dates for those next milestones.
Key Questions
What was the main business contrast in the Week 43 review?
The roundup reported growth at P&G and Puig, while online beauty sales in China declined 6 percent in September. The results cover different companies, periods and measures.
What regulatory developments affected cosmetics?
The UK proposed tighter restrictions on some high-risk cosmetic procedures, and Indonesia extended halal certification deadlines for cosmetics and personal care products to 2028.
Did the FDA approve an injectable treatment for under-eye hollows?
No such approval is reported. The FDA cleared a Phase 2 clinical trial investigating injectable PDGF; trial clearance is not the same as approval for general use.
What disruptions did the roundup report?
It reported Sephora store closures in France and temporary luxury-store closures in Milan amid civil unrest. It also said a Russian attack damaged Ukrainian personal care manufacturer 2K and forced a production halt.
Source: rss
